Diagnostic Steps In The Evaluation Of Patients With Erectile Dysfunction
2002; Lippincott Williams & Wilkins; Volume: 168; Issue: 2 Linguagem: Inglês
10.1016/s0022-5347(05)64690-3
ISSN1527-3792
AutoresDimitrios Hatzichristou, Konstantinos Hatzimouratidis, Michael Bekas, Apostolos Apostolidis, Vasilios Tzortzis, Konstantinos Yannakoyorgos,
Tópico(s)Sexuality, Behavior, and Technology
ResumoNo AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Aug 2002Diagnostic Steps In The Evaluation Of Patients With Erectile Dysfunction Dimitrios Hatzichristou, Konstantinos Hatzimouratidis, Michael Bekas, Apostolos Apostolidis, Vasilios Tzortzis, and Konstantinos Yannakoyorgos Dimitrios HatzichristouDimitrios Hatzichristou , Konstantinos HatzimouratidisKonstantinos Hatzimouratidis , Michael BekasMichael Bekas , Apostolos ApostolidisApostolos Apostolidis , Vasilios TzortzisVasilios Tzortzis , and Konstantinos YannakoyorgosKonstantinos Yannakoyorgos View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)64690-3AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: The necessity for a thorough diagnostic evaluation for erectile dysfunction has been questioned after the availability of effective oral therapies. We determined the impact of the different diagnostic steps on the management strategy for erectile dysfunction. Materials and Methods: The study included all patients who presented at an andrology outpatient clinic during a 4-year period. Baseline evaluation included medical and sexual history, blood tests, physical examination and intracavernous injection test. Patients with normal initial screening were evaluated with specific diagnostic procedures. The results were analyzed to identify the diagnostic potential of each screening step separately. Results: Overall 1,644 patients presented at the clinic during the study period, of whom 368 (22.4%) were excluded from study due to severe psychiatric (5.2%) or cardiovascular (2.7%) disease, or to a history of erectile dysfunction less than 3 months in duration (14.5%). In the remaining 1,276 patients with a mean age plus or minus standard deviation of 56 ± 14 years, and a mean duration of erectile dysfunction of 4.9 ± 3.4 years medical history revealed erectile dysfunction associated medical conditions in 57%, blood tests identified previously undiagnosed medical conditions in 6.2%, and physical examination and the intracavernous injection test were diagnostic in 13.9% and 2.6%, respectively. Initial screening was negative in 259 cases (20.3%), in which specific diagnostic procedures identified an underlying vascular pathology in 165 (12.9%) and unfavorable penile geometry in 16 (1.3%). The remaining 78 men (6.1%) had no evidence of organic disease. Conclusions: Baseline diagnostic evaluation for erectile dysfunction can identify the underlying pathological condition or erectile dysfunction associated risk factors in 80% of patients. Such screening may diagnose reversible causes of erectile dysfunction and also unmask medical conditions that manifest with erectile dysfunction as the first symptom. Specific diagnostic procedures may be limited in patients with primary erectile dysfunction or those without risk factors. Such clinical data support previously published guidelines for erectile dysfunction management. References 1 : Impotence. N Engl J Med1989; 321: 1648. Google Scholar 2 : Erectile dysfunction. N Engl J Med2000; 342: 1802. Google Scholar 3 : New method for continuous measurement of nocturnal penile tumescence and rigidity. Urology1985; 26: 4. Google Scholar 4 : Diagnosis and therapy of erectile dysfunction. In: . Philadelphia: W. B. Saunders1992: 3033. chapt. 84. Google Scholar 5 : Correlation of penile duplex ultrasonography, PBI, DICC and angiography in the diagnosis of impotence. Int J Impot Res1998; 10: 153. Google Scholar 6 : Various applications of corpus cavernosography. Radiology1976; 119: 69. Google Scholar 7 : A pill for impotence. N Engl J Med1998; 338: 1458. Google Scholar 8 : Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med1998; 338: 1397. Google Scholar 9 : The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology1997; 49: 822. Crossref, Medline, Google Scholar 10 : Basic assessment of the patient with erectile dysfunction. In: Textbook of Erectile Dysfunction. Edited by . Oxford: Isis Medical Media1999: 195. Google Scholar 11 : The process of care model for evaluation and treatment of erectile dysfunction. Int J Impot Res1999; 11: 59. Google Scholar 12 : Recommendations of the 1st International Consultation on Erectile Dysfunction. In: Erectile Dysfunction. Edited by . Plymouth, United Kingdom: Health Publication2000: 709. Google Scholar 13 : Nocturnal penile tumescence and rigidity monitoring in young potent volunteers: reproducibility, evaluation criteria and the effect of sexual intercourse. J Urol1998; 159: 1921. Link, Google Scholar 14 : Dynamic color doppler sonography in the evaluation of penile erectile disorders. Int J Impot Res1994; 6: A30. Google Scholar 15 : Phalloarteriography in the diagnosis of erectile impotence. World J Surg1978; 2: 239. Google Scholar 16 : Penile xenon (133Xe) washout: a rapid method of screening for vasculogenic impotence. Urology1984; 23: 31. Google Scholar 17 : Neurophysiological studies of sexual dysfunction. In: Sexual Dysfunction: A Neuromedical Approach. Edited by . New York: Futura Publishing1994: 101. Google Scholar 18 : Diurnal penile tumescence recording in the etiological diagnosis of erectile dysfunction. J Urol1994; 152: 1111. Abstract, Google Scholar 19 : A therapeutic taxonomy of treatments for erectile dysfunction: an evolutionary imperative. Int J Impot Res1997; 9: 115. Google Scholar 20 : Sildenafil: a review of its use in erectile dysfunction. Drugs1999; 57: 967. Google Scholar 21 : A new era in the treatment of erectile dysfunction. Am J Cardiol1999; 84: 18N. Google Scholar 22 : A comparison of the response to the intracavernosal injection of a combination of papaverine and phentolamine, prostaglandin E1 and a combination of all three agents in the management of impotence. Int J Impot Res1991; 3: 113. Google Scholar 23 : Endocrine evaluation and therapy of erectile dysfunction. Urol Clin North Am1988; 15: 53. Google Scholar 24 : The natural history of impotence in diabetic men. Diabetologia1984; 26: 437. Google Scholar 25 : A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study. J Urol1994; 151: 1209. Link, Google Scholar 26 : A positive pharmacological erection test does not rule out arteriogenic erectile dysfunction. J Urol1996; 156: 1628. Link, Google Scholar 27 : Study of cavernosal arterial anatomy using color and power Doppler sonography: impact on hemodynamic parameter measurement. J Urol1999; 162: 358. Abstract, Google Scholar 28 : Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel. Am J Cardiol2000; 86: 175. Crossref, Medline, Google Scholar From the Department of Urology and Center for Sexual and Reproductive Health, Aristotle University of Thessaloniki, Thessaloniki, Greece© 2002 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 168Issue 2August 2002Page: 615-620 Advertisement Copyright & Permissions© 2002 by American Urological Association, Inc.Keywordspenisimpotenceguidelinesdiagnostic tests, routinealgorithmsMetricsAuthor Information Dimitrios Hatzichristou More articles by this author Konstantinos Hatzimouratidis More articles by this author Michael Bekas More articles by this author Apostolos Apostolidis More articles by this author Vasilios Tzortzis More articles by this author Konstantinos Yannakoyorgos More articles by this author Expand All Advertisement PDF downloadLoading ...
Referência(s)